Health center named for ‘ghost doctor' serves thousands of patients in Nashville
'Last year was a stellar year, we were almost at 19,000 patients, compared to about 17,000 patients in 2023, and so we're continuing to grow,' said Katina Beard, CEO of Matthew Walker Comprehensive Health Center.
The health center has two locations in addition to their main building in North Nashville, which is where Dr. Temicka Logan's career came full circle, serving dental patients in her own hometown.
'I am from Nashville, born and raised,' she said. 'I had braces in high school and I just loved how it shaped my teeth. I have a different smile so I was a different person, a more confident person.'
Nashville non-profit provides a simple service with a meaningful impact
Dr. Logan is now dental director at the MWCHC.
'I was too one of those families that needed help, so to be able to help other families like I was is amazing,' said Dr. Logan. 'I just want to be able to pour into the community as they poured into me.'
The historical marker outside the building on 14th Avenue North and Jefferson Street states that Dr. Matthew Walker Sr. graduated from Meharry Medical College in 1934 and became chairman of the surgery department.
'He was known across the nation as a stellar provider,' Beard explained. 'He was also known as the ghost surgeon. He would be called in during the night to perform surgeries on individuals in hospitals that were white that didn't allow for Black physicians and surgeons. So he would come in the cover of night and perform these very difficult surgeries and save lives.'
Dr. Walker was pivotal in securing a 1968 federal grant to start the Meharry Neighborhood Health Center. It was named after him a couple years later.
'I think the organization embodies his characteristics, his integrity, his vision,' said Beard.
American Baptist College president retiring after Nashville HBCU's 100th anniversary
MWCHC's breadth of services includes primary medical services, dental services, behavioral health services, lab services and radiology services, which includes mammography.
The center also has an on-site pharmacy in Nashville. Additionally, MWCHC has a sliding fee program, which is based on household income and the number of living in a home, but they also accept insurance.
'It just warms my heart that we are able to help them when they come because sometimes they come and they say, 'Well, I know they're not going to help me,' recalled Dr. Logan. 'No, we are. We're going to help you and we're going to do the best we can do our ability.'
Given all those services, the center also helps supply the workforce needed to support their patients and others.
'We probably train a couple hundred people in some discipline in some way through our various sites, and so we've held true to those tenants, providing quality healthcare and training the workforce forward,' said Beard.
News 2 On Tour | Explore the communities that shape Middle Tennessee
In addition to Nashville, MWCHC centers can also be found in Smyrna and Clarksville along with a mobile unit that goes out into the community. Beard told News 2 the center and its partners are working to provided all these services regardless of someone's ability, but added that work is getting harder.
'We've already lost about $600,000 of grant dollars that we had budgeted, and so that has caused a significant shift in the work that we thought we would be able to do,' said Beard. 'Although we're tracking along, we are tracking along cautiously, watching to see if there will be any other changes to our dollars, locally, statewide or federally.'
On Aug. 7, the Dr. Matthew Sr. Legacy Breakfast will be held at the Cal Turner Family Center to benefit MWCHC. For more information about the event, call 615-340-1292 or email Cathy Hunt at chunt@mwchc.org.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Los Angeles Times
10 hours ago
- Los Angeles Times
Life expectancy in California still hasn't rebounded since the pandemic
During the COVID-19 pandemic, the virus caused life expectancy in California to drop significantly. It's now been over two years since officials declared the pandemic-related public health emergency to be over. And yet, life expectancy for Californians has not fully recovered. Today, however, the virus has been replaced by drug overdoses and cardiovascular disease as the main causes driving down average lifespans. A new study published in JAMA by researchers from UCLA, Northwestern, Princeton and Virginia Commonwealth University finds that Californians lived, on average, nearly a year less in 2024 than they did in 2019. The shortfall of 0.86 years signals that only about two-thirds of the state's pandemic-era losses of 2.92 years have been reversed. Using mortality data from the California Comprehensive Death Files and population estimates from the American Community Survey, the researchers calculated annual life expectancy from 2019 to 2024, breaking the figures down by race, ethnicity, income and cause of death. While the COVID-19 virus was the primary factor in life expectancy declines during the pandemic's peak, accounting for 61.6% of the life expectancy gap, its impact has significantly lessened. In 2024, COVID-19 accounted for only 12.8% of the life expectancy gap compared to 2019, while drug overdoses and cardiovascular disease contributed more — 19.8% and 16.3%, respectively. For Black and Hispanic Californians, recovery has been even slower. Life expectancy for Black residents in 2024 remained 1.48 years below 2019 levels, while for Hispanic residents it was 1.44 years lower. In contrast, the gap for white residents was 0.63 years, and for Asian residents, who have the highest life expectancy in the state at 85.51 years, it was 1.06 years. Overall, the life expectancy for Black Californians in 2024 was under 73.5 years, more than a dozen years lower than that of Asian Californians. Janet Currie, a co-author of the study and professor at Princeton University, noted that these disparities are especially striking. 'You saw the very big hit that Hispanic people and Black people took during the pandemic,' she said, 'but you also see that Black people in particular are still not caught up.' She added that while Hispanic populations saw a faster rebound, they too remain behind. Income-based disparities in life expectancy persist in stark form. Californians living in the lowest-income census tracts (the bottom quartile) experienced a 0.99-year gap in 2024 compared to 2019, while those in the highest-income quartile had a slightly smaller 0.85-year gap. However, the overall life expectancy difference between these groups, 5.77 years, was nearly identical to the pre-pandemic gap of 5.63 years, suggesting that income-based health disparities persist even as pandemic impacts recede. The study highlights drug overdoses as a primary post-pandemic driver of reduced life expectancy. Black Californians and residents of low-income areas were especially affected. In 2023, drug overdoses contributed nearly a full year (0.99 years) to the life expectancy deficit for Black Californians and over half a year (0.52) for residents of low-income areas. That said, there are signs that state and national efforts to address the overdose crisis may be yielding early results. The number for Black Californians declined to 0.55 years in 2024 while it declined to 0.26 years for residents in low income areas; in the same time frame, the statewide number dropped from 0.4 years to 0.17 years. Currie attributed the initial surge in overdose deaths in part to the pandemic itself — there were disruptions in access to treatment, and many Californians suffered greater isolation. While she welcomed the recent progress, she cautioned that the share of deaths attributable to overdoses remains high and emphasized that this was 'one of the real bad consequences of the pandemic.' Meanwhile, cardiovascular disease is now the leading contributor to life expectancy loss among high-income Californians. In 2024, it accounted for 0.22 years of the gap for the wealthiest quartile, more than COVID-19 did at 0.10 years. The authors note this is consistent with statewide rising rates of obesity, which may be playing a role. Tyler Evans, chief medical officer and CEO of Wellness Equity Alliance as well as the author of the book 'Pandemics, Poverty, and Politics: Decoding the Social and Political Drivers of Pandemics from Plague to COVID-19,' emphasized how the pandemic exacerbated long-standing health inequities. 'These chronic health inequities were further amplified as the result of the pandemic,' he said. While investments in social determinants of health initially helped mitigate some of the worst outcomes, he added, 'the funding dried up,' making recovery harder for communities already at greater risk of poor outcomes. Evans also pointed to a broader pattern of overlapping health crises that he described as a 'syndemic,' a convergence of epidemics like addiction, chronic disease and poor access to care that interact to worsen outcomes for historically marginalized populations. 'Until we invest in that sort of foundation long term, the numbers will continue to decline,' he said. 'California should be a leader in health improvement outcomes in the country, not a state that continues to have our survival decline.' Although the findings are limited to California and based on preliminary 2024 data, the study provides an early glimpse into post-pandemic mortality trends ahead of the Centers for Disease Control and Prevention's national life expectancy dataset, expected to be published later this year. California, home to one-eighth of the U.S. population, provides valuable insight into how racial, ethnic and socioeconomic disparities continue to shape public health. Ultimately, the study highlights how although the most visible impacts of COVID-19 may have faded, their ripple effects, compounded by ongoing structural inequities, continue to shape life and death in California. The pandemic may have accelerated long-standing public health challenges, and post-pandemic recovery, the study makes clear, has been uneven and incomplete. Currie warned that further cuts to Medicaid and public hospitals could make these gaps even worse. 'We know what to do. We just don't do it,' she said.
Yahoo
18 hours ago
- Yahoo
The American diet is being blamed for a worrying rise in colon cancer
Rates of colorectal and other gastrointestinal cancers are rising in Americans under the age of 50, researchers said Tuesday. They may know why. An increased risk of early-onset gastrointestinal cancers is associated with obesity, which is also rising in the U.S. That's what scientists say is a 'leading theory' for the surge - noting a 2019 study that found women who were considered obese had nearly double the risk of developing early-onset colorectal cancer. Close to half of all U.S. adults are predicted to be obese by 2030, according to research released the same year. The chronic condition can cause inflammation and higher levels of insulin that increases peoples' risk of getting cancer, including several types of gastrointestinal cancers, according to the Centers for Disease Control and Prevention. Other risk factors include smoking, drinking alcohol, eating a Western-style diet and non-alcoholic fatty liver disease. Earlier this year, new research pointed to the impact of a toxin in the gut, known as colibactin, that can inflict DNA damage on colon cells that leads to the development of cancer. Colibactin is produced by the bacteria E. coli, which is often responsible for foodborne illness. As of now, the specific cause remains unclear but the U.S. is not alone, researchers said. 'The incidence of GI cancers in adults younger than age 50 is rising globally,' explained Boston's Dana-Farber Cancer Institute oncology fellow Dr. Sara Char. In the U.S., scientists found that early-onset cases have shown a 'marked increase' in both American men and women since the mid-1990s. In comparison to American adults born in 1950, those born in 1990 have twice the risk of developing colon cancer and four times the risk of developing rectal cancer, the researchers found. Furthermore, early-onset colorectal cancer has become the leading cause of cancer-related deaths in U.S. for men under 50. For women in the same age group, it's the second-leading cause of cancer-related deaths. Colorectal cancer, the most common type of gastrointestinal cancer, also affects Black, Hispanic, Indigenous, and Asian people disproportionately. These and other related findings signal a worrying shift — and potentially a need for updated treatment practices, the researchers noted. Patients with early-onset colorectal cancers often experience delays in diagnosis because neither doctors, nor their patients, suspect cancer and doctors are more likely to diagnose patients when they are at advanced stages of the disease. Younger patients are more likely to receive aggressive treatment, 'often without a survival advantage,' they said. Colorectal cancer is the third-leading cause of cancer-related deaths in American men and the fourth-leading cause in women. Overall, it's the second most common cause of U.S. cancer deaths, and the American Cancer Society says it's expected to cause about 52,900 deaths this year. The researchers pointed out that younger patients are more likely to experience financial hardship because of their diagnosis and problems with body image and mental health, as well as a worse quality of life. 'Ongoing research efforts investigating the biology of early-onset GI cancers are critical to developing more effective screening, prevention, and treatment strategies,' Char, the paper's lead author, said. The paper was published by Oxford University Press in the journal BJS.
Health Line
19 hours ago
- Health Line
Venus Williams on Uterine Fibroids: ‘My Doctors Told Me It Was Normal'
Venus Williams recently shared her journey with uterine fibroids, a condition that impacted her health and quality of life throughout her tennis career. Despite her severe symptoms, the Grand Slam champion's concerns were dismissed by doctors for years. Fibroids are noncancerous uterine tumors that often cause heavy bleeding, pelvic pain, and fertility issues. Experts emphasize self-advocacy and seeking second opinions if your symptoms are dismissed. Venus Williams, one of the most decorated tennis stars in history, recently opened up about her battle with uterine fibroids. Williams, 45, said the condition took a toll on her health, tennis career, and quality of life for nearly 30 years. In an interview with NBC News Now, the seven-time Grand Slam champion described how her fibroid symptoms, ranging from intense cramps to heavy bleeding, nausea, and persistent anemia, became a monthly battle. 'I was hugging the toilet, waiting for it to pass,' she shared. Williams said that although she knew she had fibroids, she didn't realize how large or severe they were, and her concerns were repeatedly dismissed by doctors. 'As bad as things were for me, crazy amounts of bleeding like you couldn't imagine … my doctors told me it was normal,' she said. During the 2016 Wimbledon tournament, the pain became so intense that Williams collapsed in the locker room. Her sister Serena Williams had to call for medical aid. 'I was lying on the locker room floor, unable to move,' she recalled. Williams said it wasn't until she found NYU Langone's Center for Fibroid Care that she finally received effective treatment for her fibroids. 'No one should have to go through this,' she said. 'You don't have to live this way.' Here's what to know about fibroids and their symptoms, and why clinicians may dismiss the condition. What are fibroids? While the exact causes of fibroids are not known, hormones and genetic factors may play a role in their development. 'Fibroids are noncancerous tumors of the uterus made of muscle and fibrous tissue,' explained Esohe Faith Ohuoba, MD, MPH, a board certified OB-GYN at Memorial Hermann Medical Group Kingwood and Memorial Hermann Convenient Care Center in Summer Creek, in Humble, TX. 'They can range in size from a seed to a melon,' she told Healthline. Ohuoba said that around 70% of women will develop fibroids by the age of 50, and that percentage increases for many women of color, specifically Black women, where the number rises to 80%. 'Black women are three times more likely to develop fibroids than white women. They also tend to be diagnosed younger, often in their 20s and 30s,' Obuoba said. Fibroids are often asymptomatic, which means you might not experience any symptoms at all. However, symptoms can include heavy or prolonged menstrual bleeding, pelvic pain or pressure, bloating, frequent urination, and pain during sex. 'In some cases, fibroids can impact fertility or pregnancy, and the chronic nature of these symptoms can interfere with work, relationships, emotional well-being, and overall quality of life,' said Arielle Bayer, MD, reproductive endocrinologist and infertility specialist at CCRM Fertility in New York City. Fibroid pain may be dismissed Fibroids have been somewhat elusive in clinical settings until recently. They're notoriously difficult to diagnose and often missed by doctors who might mistake their symptoms for another condition affecting reproductive health. Fibroid symptoms can be debilitating, however. As with Venus Williams, some women may find their pain is not taken seriously or is even dismissed in clinic settings. This may be particularly true for women of color. Ohuoba said a lack of awareness of the condition is a huge part of this issue. 'Unfortunately, patients do not realize their symptoms are a problem that needs attention because having difficulty or pain with menstruation is normalized,' she explained. She emphasized the importance of patient and clinician awareness and education. 'Even Venus mentioned seeing a social post that caught her attention and prompted her to learn more,' she pointed out. 'In clinical settings, lack of empathy and unconscious bias are reasons why women of color can be dismissed and minimized,' she continued. 'Furthermore, with fibroids specifically, there is a huge comfort with offering hysterectomy for fibroids first or in totality, which is another reason why symptom dismissal can occur.' Why self-advocacy is so important If you're experiencing symptoms that may be fibroids or another reproductive health issue, it's important to advocate for yourself to get the care you need. 'This is especially important because women of color often receive a delay in diagnosis, which can often lead to larger fibroids and more severe symptoms,' Ohuoba said. Bayer recommended trusting your instincts. 'If you feel your concerns are being minimized, it's OK to seek a second, or even third, opinion,' she told Healthline. 'Keep a detailed symptom journal and bring it with you to appointments. Don't be afraid to ask direct questions about imaging, diagnosis, and treatment options,' she added. Ohuoba said choosing your healthcare provider carefully is also key. 'Seeking out providers experienced in treating fibroids and understanding your health goals will help you feel empowered about your ability to navigate your diagnosis,' she said. How are fibroids treated? As awareness of fibroids broadens, more treatment options have become available. One approach is watchful waiting. 'This is where your healthcare provider will monitor you for changes,' Ohuoba explained. 'There are also medications such as hormonal birth control, GnRH agonists, and tranexamic acid,' she continued. Treatment may depend on whether preserving fertility is a priority. 'Uterine artery embolization (UAE) and ultrasound-based fibroid treatments are generally considered options when fertility preservation is not a priority,' explained Bayer. 'These approaches may be appropriate in select cases but are typically reserved as alternatives when childbearing is not a concern.' A hysterectomy is another option, which involves the complete removal of the uterus. For those who wish to maintain fertility, minimally invasive procedures like hysteroscopic or laparoscopic myomectomy are preferred. Alternatively, a newer treatment option known as radiofrequency ablation (Acessa procedure) uses heat to destroy fibroid tissue. 'This procedure is minimally invasive and uses small incisions in the abdomen that allow access to the uterus to target the fibroids,' Ohuoba explained. Getting a diagnosis for fibroids can be a challenge, especially for women of color. This underpins the importance of self-advocacy and finding the right healthcare professional.
